Signs and symptoms | All Patients with pSS, n = 51 | pSS + COPD, n = 21 | pSS – COPD, n = 30 | p, pSS + vs–COPD |
---|---|---|---|---|
ESSDAI respiratory domain score > 0 | 55 | 52 | 57 | 0.762 |
Low activity | 39 | 38 | 40 | 0.891 |
Moderate activity | 14 | 10 | 17 | 0.685 |
High activity | 2 | 5 | 0 | 0.412 |
ESSPRI total score | 6 ± 2 | 6 ± 3 | 6 ± 2 | 0.281 |
SGRQ total score | 21 ± 16 | 24 ± 17 | 19 ± 16 | 0.232 |
SGRQ symptom score | 27 ± 22 | 31 ± 20 | 24 ± 22 | 0.185 |
SGRQ activity score | 33 ± 24 | 36 ± 27 | 31 ± 23 | 0.527 |
SGRQ impact score | 13 ± 14 | 15 ± 15 | 11 ± 13 | 0.403 |
Radiographic findings | ||||
Radiographic abnormalities | 65 | 81 | 53 | 0.073 |
Air trapping | 35 | 38 | 33 | 0.726 |
Reticular pattern | 33 | 52 | 20 | 0.016 |
Central bronchiectasis | 26 | 43 | 13 | 0.024 |
Traction bronchiectasis | 8 | 5 | 10 | 0.634 |
Cysts | 29 | 24 | 33 | 0.463 |
Emphysema | 14 | 29 | 3 | 0.015 |
Ground glass attenuation | 12 | 5 | 17 | 0.381 |
Honeycombing | 0 | 0 | 0 | NA |
ILD signs | 17 | 10 | 23 | 0.277 |
ESSDAI: EULAR Sjögren Disease Activity Index; ESSPRI: EULAR Sjögren Patient Reported Index; SGRQ: St. George’s Respiratory Questionnaire; pSS: primary Sjögren syndrome; COPD: chronic obstructive pulmonary disease; ILD: interstitial lung disease; NA: not assessed; EULAR: European League Against Rheumatism.